Vaccines against smallpox are known to have cross-protective activity against monkeypox, and smallpox and monkeypox infections are believed to generate permanent immunity. Nevertheless, there are scarce data about the possibility of reinfection or reactivation. Recently, a case of apparent monkeypox reinfection has been reported. We present a suspected case of second episode of monkeypox in a healthy and previously vaccinated man, with a confirmed primary monkeypox infection occurring three months before the second confirmed presentation.
FinePEJezekZGrabB, et al.The transmission potential of monkeypox virus in human populations. Int J Epidemiol1988 Sep; 17(3): 643–650.
3.
JezekZSzczeniowskiMPalukuKM, et al.Human monkeypox: clinical features of 282 patients. J Infect Dis1987 Aug; 156(2): 293–298.
4.
ThornhillJPBarkatiSWalmsleyS, et al.Monkeypox virus infection in humans across 16 Countries-April-June 2022. N Engl J Med. 2022 Aug 25; 387(8):679–691.
5.
Tarín-VicenteEJAlemanyAAgud-DiosM, et al.Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet2022 Aug 27; 400(10353): 661–669.
6.
JacobsBLLanglandJOKiblerKV, et al.Vaccinia virus vaccines: past, present and future. Antiviral Res2009 Oct; 84(1): 1–13.
7.
LumFMTorres-RuestaATayMZ, et al.Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol2022 Oct; 22(10): 597–613.
8.
PolandGAKennedyRBToshPK. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect Dis2022 Dec; 22(12): e349–e358.
9.
Van EwijkCEMiuraFvan RijckevorselG, et al.Monkeypox outbreak in the Netherlands in 2022: public health response, epidemiological and clinical characteristics of the first 1000 cases and protection of the first-generation smallpox vaccine. medRxiv2022. DOI: 10.1101/2022.10.20.22281284.
10.
BertranMAndrewsNDavisonC, et al.Effectiveness of one dose of MVA-BN smallpox vaccine against monkeypox in England using the case-coverage method. medRxiv2022.
11.
KaremKLReynoldsMHughesC, et al.Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol2007 Oct; 14(10): 1318–1327.
12.
CrottySFelgnerPDaviesH, et al.Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol2003 Nov 15; 171(10): 4969–4973.
13.
HammarlundELewisMWHansenSG, et al.Duration of antiviral immunity after smallpox vaccination. Nat Med2003 Sep; 9(9): 1131–1137.
14.
EnnisFACruzJDemkowiczWEJr, et al.Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. J Infect Dis2002 Jun 1; 185(11): 1657–1659.
15.
GoldenJHarrymanLCroftsM, et al.Case of apparent mpox reinfection. Sex Transm Infect2023 Jan 27: 055736.sextrans-2022.
16.
NörzDBrehmTTTangHT, et al.Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus. J Clin Virol2022 Oct; 155: 105254.
17.
PalichRBurrelSMonselG, et al.Viral loads in clinical samples of men with monkeypox virus infection: a French case series. Lancet Infect Dis2023 Jan; 23(1): 74–80.
18.
Peiró-MestresAFuertesICamprubí-FerrerD, et al.Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022. Euro Surveill. 2022 Jul; 27(28): 2200503.
19.
LapaDCarlettiFMazzottaV, et al.. Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding. Lancet Infect Dis2022 Sep; 22(9): 1267–1269.
20.
SuñerCUbalsMTarín-VicenteEJ, et al.Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain. Lancet Infect Dis2022 Dec 12; S1473-S3099(22): 00794.
21.
AdlerHGouldSHineP, et al.Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis2022 Aug; 22(8): 1153–1162.
